Results 241 to 250 of about 13,983,545 (429)

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system

Molecular Oncology, EarlyView.
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen, Saurav Subedi, Federico La Manna, Sofia Jarrin, Irida Papapostolou, Marianna Kruithof‐de Julio, Christine Peinelt   +6 more
wiley   +1 more source

TrAGEDy-trajectory alignment of gene expression dynamics. [PDF]

Bioinformatics
Laidlaw RF, Briggs EM, Matthews KR, Madany Mamlouk A, McCulloch R, Otto TD.   +5 more
europepmc   +1 more source

The action of estrogen and progesterone on the expression of the transferrin gene. A comparison of the response in chick liver and oviduct.

, 1978
D.C. Lee, G. Stanley McKnight, Richard D. Palmiter   +2 more
openalex   +1 more source

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

Molecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, Akihiro Seki, Keiko Yoshida, Kosuke Satomura, Yoshio Sakai, Shuichi Kaneko, Taro Yamashita   +8 more
wiley   +1 more source

Cell surface changes and Rous sarcoma virus gene expression in synchronized cells. [PDF]

, 1975
Arthur H. Hale, J L Winkelhake, Michael J. Weber   +2 more
openalex   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

A Clostridioides difficile cell-free gene expression system for prototyping and gene expression analysis. [PDF]

Appl Environ Microbiol
Zeng J, Wang H, Xu Y, Han J, Li Y, Wen S, Wu C, Li D, Liu Z, Zhang X, Tian G-B, Dong M.   +11 more
europepmc   +1 more source

Expression and Linkage of Genes for X-linked Hemophilias A and B in the Dog [PDF]

, 1973
K. M. Brinkhous, Peter D. Davis, John B. Graham, W. Jean Dodds   +3 more
openalex   +1 more source

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Secure and scalable gene expression quantification with pQuant. [PDF]

Nat Commun
Hong S, Walker CR, Choi YA, Gürsoy G.
europepmc   +1 more source